InsidersTradesSigma
유바이오로직스 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 유바이오로직스 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 유바이오로직스 has logged 74 reports. Market capitalisation: €347.4bn. The latest transaction was reported on 3 April 2026 (Purchase). Among the most active insiders: 바이오노트. All data is openly available.
74
Insider Decl.
0
Thresholds
·
53 ops.
Buy Volume
·
0 ops.
Sell Volume
9Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 190 of 26,270 companies
88.4
score / 100
Value90
Quality87
FCF yld11%
Earn yld14%
EV/EBITDA4.6x
ROE·
Gross mgn58%
Net mgn28%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 April 2026
Declarations74 total
25 of 74 declarations